首页> 外文期刊>Therapeutic advances in cardiovascular disease. >Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years’ experience in a single, kidney disease center
【24h】

Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years’ experience in a single, kidney disease center

机译:经活检证实为肾硬化和肾功能中度受损的患者罹患心血管疾病的风险更高:在一个肾脏疾病中心拥有15年的工作经验

获取原文
           

摘要

Nephrosclerosis progresses slowly to end-stage renal disease (ESRD) in only a small percentage of patients. However, because hypertension and nephrosclerosis are normally found simultaneously, nephrosclerosis is a risk factor for cardiovascular disease (CVD). In turn, the onset of CVD may progress to further renal impairment. To evaluate clinical outcomes and the association between nephrosclerosis and CVD in the long term. Prospective study We prospectively assessed 35 patients (male/female: 19/16) with nephrosclerosis aged 30 years at disease onset, attending the Kidney Disease Center, Saitama Medical University, in a single teaching hospital center between 1995 and 2014. Nephrosclerosis was diagnosed in accordance with the criteria outlined in the World Health Organization (WHO) monograph of renal diseases. All patients were followed by means of registries for 10 years to record subsequent events, if any. The primary study outcome was correlating the occurrence of CVD, defined as a composite of cardiovascular deaths, nonfatal and fatal myocardial infarction, and stroke, with the development of ESRD or death. The mean age of patients at the time of biopsy was 54.8 ± 12.7 years (range 33–72 years). Of these patients, seven were affected by nonfatal CVD and two died due to CVD. Only one patient developed ESRD during the follow-up period. Using Kaplan–Meier analysis, risk factors for the primary study outcome were estimated to include an estimated glomerular filtration rate (eGFR) 2, systolic blood pressure 130 mmHg and proteinuria 1 g/g creatinine. Univariate analysis was used for the assessment of the relative risk for the primary study endpoint of several covariates: age, systolic blood pressure, eGFR and proteinuria at time of renal biopsy. eGFR was found to be the strongest factor determining an event-free period [relative risk (RR) =1.931, p = 0.014]. Patients with nephrosclerosis are at high risk of CVD when they have moderately advanced renal impairment.
机译:肾硬化仅在少数患者中缓慢进展为终末期肾病(ESRD)。但是,由于通常同时发现高血压和肾硬化,因此肾硬化是心血管疾病(CVD)的危险因素。反过来,CVD的发作可能会进一步发展为肾功能不全。长期评估临床结果以及肾硬化与CVD之间的关联。前瞻性研究我们前瞻性评估了1995年至2014年间在一家教学医院中心就诊的35例年龄> 30岁,发病年龄> 30岁的肾硬化患者(男/女:19/16)在Sa玉医科大学肾脏病中心的病情。根据世界卫生组织(WHO)肾脏疾病专论中概述的标准。所有患者均经过登记10年,以记录后续事件(如有)。主要研究结果是将CVD的发生与ESRD或死亡的发生相关联,CVD的发生是心血管死亡,非致命性和致命性心肌梗塞以及中风的综合。活检时患者的平均年龄为54.8±12.7岁(33-72岁)。在这些患者中,有7人受到非致命性CVD的影响,其中2人因CVD死亡。在随访期间只有一名患者发生了ESRD。使用Kaplan-Meier分析,初步研究结果的危险因素包括肾小球滤过率(eGFR)2,收缩压> 130 mmHg和蛋白尿> 1 g / g肌酐。单因素分析用于评估几个协变量的主要研究终点的相对风险:肾脏活检时的年龄,收缩压,eGFR和蛋白尿。发现eGFR是决定无事件期的最强因素[相对风险(RR)= 1.931,p = 0.014]。肾硬化患者中度晚期肾功能不全时,发生CVD的风险较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号